Mesirow Institutional Investment Management, Inc. Biomarin Pharmaceutical Inc Transaction History
Mesirow Institutional Investment Management, Inc.
- $1.27 Billion
- Q3 2024
A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 398 shares of BMRN stock, worth $25,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
398
Previous 40,788
99.02%
Holding current value
$25,253
Previous $3.36 Million
99.2%
% of portfolio
0.0%
Previous 0.31%
Shares
9 transactions
Others Institutions Holding BMRN
# of Institutions
636Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.22 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.2 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$882 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$666 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...